ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Trends in cannabis use among those with and without a cancer diagnosis according to state-level cannabis policy: findings from the PATH Study, Waves 1-5 (2013-2019).
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial: The role of cannabinoids and the endocannabinoid system in anti-cancer therapy.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIndividual states have implemented legal cannabis policies. Individuals with a cancer diagnosis increasingly consume cannabis. It is uncertain whether state-level cannabis policies are differentially associated with trends in cannabis use among those diagnosed with cancer vs. those without. We compared trends in cannabis use prevalence across time, over cannabis legal status, among those with vs. without a cancer diagnosis.
methodsData are from five Waves of the nationally representative PATH Study (2013-2019). Trends in past-year prevalence of cannabis use were examined between those with vs. without a cancer diagnosis and stratified by state cannabis policy at the time of data collection (illegal, medical-legal, non-medical legal). Demographic and policy correlates of cannabis use were compared between those with vs. without a cancer diagnosis.
resultsRegardless of policy context, the prevalence of cannabis use increased among those without a cancer diagnosis (11.8% in 2013, 18.6% in 2019). The prevalence of cannabis use was highest among those living in states with legalized non-medical cannabis policies. Trends among those with a cancer diagnosis aligned with trends among people without a diagnosis (55-60% increase, 2013-2019), albeit at lower prevalence (6.6% in 2013, 10.6% in 2019). Similar trends between those with a cancer diagnosis and those without were observed regardless of policy status.
conclusionTrends in the prevalence of cannabis use among individuals with a cancer diagnosis mirrored trends in the population of individuals without cancer. State cannabis policies appear not to be uniquely associated with cannabis use prevalence among people with a cancer diagnosis.
Indexed as
Identifiers
40490566What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.